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ABSTRACT 
An integrated lateral flow device for flow control and blood separation 
Veronica Betancur Calle 
Lateral flow devices (LFD) have been used and are promising in many applications, 
including point-of-care diagnosis in medical, clinical, food and environmental control and 
monitoring. In particular, disposable paper-based lateral flow strips utilize low-cost materials and 
do not require expensive fabrication instruments. Many examples of diagnostic tests have been 
developed using microfluidics paper analytical devices (μPADs), including tests for the detection 
of total glucose and protein in urine (colorimetric), detection of β-galactosidase (fluorescence), 
and liver enzyme tests for monitoring the health of patients been treated with multiple 
medications for HIV and/or  tuberculosis that can cause hepatotoxicity. However, there are 
constraints on tuning the flow rate and immunoassays functionalization in paper as well as 
technical challenge in integration of sensors and concentration units for low-abundant molecular 
detection. In the present work, we demonstrated an integrated lateral flow device that applied the 
capillary forces with functionalized polymer-based microfluidics as a strategy to realize a 
portable, simplified, and self-powered LFD with minimizing the need for off-chip equipment. 
The LFD combined the ability to separate plasma from human whole blood and create controlled 
and steady flow using capillary forces. Lateral flow relies on surface tension and hydrophilic 
natural of the flow channel, and controlled flow is also a key variable for immunoassay-based 
applications for providing enough time for protein binding to antibodies. To render 
polydimethylsiloxane (PDMS) surface of hydrophilicity as well as to control the flow rate, 
PDMS was functionalized with different concentrations of Pluronic F127. The results show that, 
in an integrated LFD, the flow rate was regulated by the combination of multiple factors, 
including Pluronic F127 functionalized surface properties of microchannels, resistance of the 
integrated flow resistor, the dimensions of the microstructures and the spacing between them in 
the capillary pump, the contact angles, and viscosity of the fluids. The resistance of the flow 
resistor had the greatest effect on the flow rate of the fluids. Plasma flow rates ranging between 
0.43 and 18.60 nL/s were achieved in the flow resistor, and between 0.99 and 61.30 nL/s in the 
whole device. In addition, human plasma was separated from whole blood by using a highly 
asymmetric plasma separation membrane, which captured the cellular components of the blood 
(red cells, white cells, and platelets), without lysis, so that only high quality plasma could flow 
down into the smaller pores on the downstream side of the membrane, and into the first capillary 
pump. The developed LFD can be used as a flexible and versatile platform and has the potential 
for detecting circulating biomarkers from whole blood; sandwich-immunoassays can be 
performed directly on the LFD by patterning receptors for analytes on the glass chip, and 
detection can be performed using a variety of methods ranging from colorimetric and 
fluorescence methods to more complex methods such as Surface-enhanced Raman spectroscopy 
(SERS) depending on the limit of detection of the target biomarker. The bio sensing technology 
being described presents an alternative for point of care testing using small samples of human 
whole blood; it could benefit regions with limited access to healthcare, where delays in diagnosis 
can lead to the quick deterioration of the quality of life and increase the morbidity and mortality.
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Chapter 1 Thesis Overview 
1.1 The Importance of Strategy Implementation 
Because financial resources are limited in developing countries, their habitants tend to 
have less access to proper health services as a result of the high cost of current detection and 
monitoring methods, which are often time consuming and do not provide immediate results, 
delaying the process of targeting, and controlling the disease in order to prevent its worsening [1]. 
The delay in diagnosis, limitation in monitoring capabilities, and obstruction of the prevention of 
risk factors will lead to the deterioration of the quality of life of the patients and increase the 
morbidity and mortality in these areas. The outcome is a vicious cycle where poverty leads to the 
decrease in health quality, and the decrease in health quality results in further socioeconomic 
deterioration.         
Proper and on time intervention could change the clinical outcome of the patients by 
decreasing the negative impact in the quality of life by avoiding the functional deterioration left 
by the aftermath and reducing the comorbidities and cost of treatment, the number of required 
hospitalizations, and the mortality rate. With this in mind, there is an increasing need of methods 
that allow assessing health status, disease onset and progression, and monitoring treatment 
outcome for the study of these patients [2]. These methods must be user friendly, cost efficient, 
reliable, portable, and generate fast results. 
The second half of the 20th century has brought great advances in biochemistry and 
technology, leading to greater sensitivity and more specific analysis of samples [3]. A 
manifestation of this potential is in the emergence of microfluidic bioanalysis. The science of 
Microfluidics concerns the controlled transport of low volumes of fluid, and it is the key for 
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miniaturization, as well as the integration of multiple functionalities, allowing for the 
performance of complete laboratory protocols on a single chip [4], [5]. Performing analytical and 
diagnostic tasks in microfluidic-based systems presents several advantages, including small 
sample volume requirements, rapid transport times and portability, as well as allowing for 
continuous flow with high precision, greatly improving the efficiency and reliability of devices 
for point-of-care diagnostics [6]–[8]. Ideally, a microfluidic system should self-contained, simple 
to use, flexible, robust, and its fabrication should be uncomplicated [9]. Low cost is important 
because it allows delivering the technologies to a wider population. Sensitivity leads to more 
reliable tests, reducing the possibilities of obtaining false positives or false negatives. As users 
might come from diverse backgrounds and might not have a deep understanding of the working 
mechanism, these devices must be easily operated and interpreted. These technologies could aid 
reach many people in need, not only through point-of-care but also through prevention public 
health brigades for marginalized and captive populations. 
Unfortunately, the application of such systems in home and point-of-care situations has 
been limited because they typically require external macroscopic actuators, bulky fluidic 
connections, and electromechanical interfaces to initiate and control fluid flow [6], [9]–[12]. 
Passive flow methods are an alternative in overcoming this limitation, because they demand no 
external power input, making them quite compact and thus portable; resulting in attractive 
analytical tools for applications such as single use assays and simple diagnostics [6]. Capillary-
based pumping takes advantage of surface tension to pull fluid through the device, so the fluid 
needs only to be delivered to an inlet region (usually via pipette); the spontaneous filling of the 
microfluidic network (μFN) which follows, and the subsequent continuous flow are function of 
the device’s design [6], [8].    
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1.2 Research Objective  
 
The main objective of this research is to develop a functionalized polymer based lateral 
flow device (LFD) with integration of function units for studying the capillary flow and 
controlling the flow rate, with the ultimate goal for the assessment of health status, disease onset 
and progression, and monitoring treatment outcome. Biomarkers are measurable biological 
characteristics that can serve as indicators of normal biological processes, pathogenic processes, 
pharmacologic responses to therapeutic intervention, and the risk or the presence of a disease. 
The objective measurement and evaluation of circulating biomarkers can therefore help in the 
assessment of the biological state of a person.  
The developed platform should be able to separate plasma from human whole blood, 
create steady flows and control the rate of flow by using passive microfluidics, and have the 
potential for detecting circulating biomarkers from the separated plasma. Specifically, the 
research focuses on: 
1) Development of a microfluidic platform that operates under capillary forces to initiate 
and control the fluid flow. Capillary action was achieved by two means: the use of capillary 
pumps, and the surface functionalization of the polydimethylsiloxane (PDMS) using Pluronic 
F127. Capillary pumps (CPs) comprise microstructures of diverse shapes, with dimensions in the 
micrometer range, whose position in the CPs encodes the desired capillary pressure. Because 
PDMS has a hydrophobic nature, its surface was functionalized with Pluronic F127 to render it 
hydrophilic.  
2) Develop strategies to control the rate of flow, which would allow for providing enough 
time for protein binding to antibodies and biomarker detection in the future. The binding reaction 
4 
 
between the antigen and the detection and capture antibodies takes a determined amount of time 
to reach equilibrium, making the time available for binding a critical factor in the optimization of 
an immunoassay. The flow rate was regulated by the combination of multiple factors, including 
Pluronic F127 functionalized surface properties of microchannels, resistance of the integrated 
flow resistor, the dimensions of the microstructures in the capillary pumps and the spacing 
between them, contact angles, and viscosity of the fluids.   
3) Integration of plasma separation membrane for performing in-situ plasma separation 
from human whole blood. The highly asymmetric nature of a plasma separation membrane 
allows the cellular components of the blood (red cells, white cells, and platelets) to be captured 
in the larger pores without lysis, while the plasma flows down into the smaller pores on the 
downstream side of the membrane.  
4) The method for sensor chip integration which can provide a convenient and easy way 
to work with different sensing approaches, including but not limited to colorimetry and 
fluorescence. This large degree of flexibility will allow for performing different types of 
immunoassays.  
1.3 Significance and Novelty 
 
Commonly used methods for quantification of protein markers in clinical setting are 
immunonephelometry or enzyme-linked immunosorbent assay (ELISA). Both require a 
centralized lab to separate whole blood and to perform multiple strict washing steps over several 
hours. There is a strong incentive to develop a rapid point-of-care (POC) device for protein 
biomarker detections with improved diagnostic modalities, enable of using minimal amounts of 
blood, and capable of returning a rapid result.  
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In an attempt to address this necessity, several microfluidic devices have been fabricated 
in the past with the goal of performing only a single task on a microliter volume of sample [13]. 
However, would it not be more effective and practical to combine the functions of different such 
devices on an integrated microfluidic chip, instead of having to perform each task separately on 
different devices? Although the degree of complexity increases with the integration, integrated 
microfluidic devices offer several advantages, including a higher degree of accuracy, 
contamination control, ease of use, rapid results, and low cost [13]. It is much easier to utilize a 
single integrated device rather than using several chips, not to mention that integrated systems 
can accurately control the amount of reaction agents and synchronize the reaction time in 
different reactors [13].  
The research work in this thesis demonstrated an integrated passive microfluidic pumping 
mechanism as an alternative noninvasive monitoring tool for clinical diagnostics requiring only 
30-40 µL of blood. Blood was selected as the working fluid as various disease-signaling 
biomarkers can be found in it, accurately reflecting normal and disease states in humans. This 
platform combines the ability to perform plasma separation from human whole blood, control the 
flow rate, integrate the detection sensor, and perform biomarker sensing all in one chip, which 
shortens the time of sample processing as well as allowing for rapid detection. It further 
eliminates the need for blood sample pretreatment in a centralized laboratory prior to the 
detection. The flow in the lateral flow device is powered by the capillary force, which was 
accomplished by two means: the use of capillary pumps (CPs) [11], and the surface 
functionalization of the PDMS using Pluronic F127 [12], thus eliminating the need of external 
power and reducing the cost.  
6 
 
In order to extend the performance of capillary systems (CSs), we designed, fabricated 
and tested a range of CSs, and compared their experimental filling behavior. The CSs were 
fabricated on polydimethylsiloxane (PDMS) using soft lithography, and sealed with a blank 
piece of PDMS. Because PDMS is of hydrophobic nature, it suffers serious nonspecific protein 
adsorption, therefore requiring of surface modification strategies [12]. Nonionic surfactants can 
adsorb strongly on hydrophobic surfaces rendering them hydrophilic and nonionic, preventing 
the interaction between proteins and the surface [12], with this in mind, PDMS surface was 
functionalized with Pluronic F127 to render it hydrophilic. The concentration of Pluronic was 
optimized for the sake of controlling the flow rate, allowing performing reliable sandwich 
immunoassays for biomarker detection. In addition, the Pluronic F127-modified PDMS has been 
shown to significantly suppress the non-specific adsorption of proteins due to the improved 
hydrophilicity, compared to native PDMS [14], [15].  
 The promise of this novel LFD lies in its potential for point of care applications, offering 
an integrated and flexible platform, which can perform full laboratory procedures for the rapid 
and proper diagnosis in one single chip. 
1.4 The Outline of the Thesis 
 
This thesis consists of six chapters. It is initiated with the thesis overview in Chapter 
One, in which the importance of strategy implementation, research objectives, significance, and 
novelty of this research were stated. Following chapter one, six chapters introduced the details of 
the research work. Chapter Two is an introduction to the microfluidics field, including its 
history, and the state-of-art of point of care devices for health applications. Chapter Three 
described the theory behind capillary phenomena. Chapter Four introduced the design of the 
7 
 
integrated lateral flow device, demonstrated fabrication procedures and testing methodology. 
Chapter Five characterized the flow rate control with the combined analysis of static/dynamic 
contact angles, functionalization of PDMS, and flow resistance, as well as the blood separation 
capabilities. Conclusions and future directions are summarized in Chapter Six.  
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Chapter 2 Literature Review  
 
2.1 Microfluidics for point of care immunodiagnostics 
 
The second half of the 20th century has brought great advances in biochemistry and 
technology, leading to greater sensitivity and more specific analysis of samples [3]. A 
manifestation of this potential is in the emergence of microfluidic bioanalysis.  
The science of Microfluidics concerns the controlled transport of low volumes of fluid, and it is 
the key for miniaturization, as well as the integration of multiple functionalities, allowing for the 
performance of complete laboratory protocols on a single chip [4], [5]. Microfluidics are 
versatile, and serve a wide variety of purposes such as medical, agriculture, environmental (e.g. 
toxicity detection), and military applications.  
The most promising opportunities of microfluidics for diagnostics might reside in point 
of care (POC) applications due to their portability, short sample processing time, small sample 
requirements, ease of use, multiplexing capability, flexibility, and their ability to carry out 
separations and detections with high resolution and sensitivity [3], [4], [16], [17]. Thanks to 
these technologies, the process of targeting and controlling diseases in order to prevent their 
worsening can be performed much earlier, providing patients with a much better quality of life, 
and increasing the probabilities of a favorable outcome. However, the application of such 
systems in home and point-of-care situations has been limited because they typically rely on 
external macroscopic actuators, bulky fluidic connections, and electromechanical interfaces to 
initiate and control fluid flow [4], [6], [9]–[12]. Capillary phenomena can serve as a substitute to 
these external equipment in view of autonomously transporting these small volumes of fluid for 
fueling miniature scaled bio/chemical processes [4]. 
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We owe the existence of microfluidics to four main motivational forces: molecular 
analysis, biodefence, molecular biology and microelectronics [16]. First came analysis. 
Microanalytical methods such as gas-phase chromatography (GPC), high-pressure liquid 
chromatography (HPLC) and capillary electrophoresis (CE) allowed for manipulating liquids at 
high precision, and when combined with the power of the laser for optical detection, they made it 
possible to achieve high sensitivity and high resolution with low sample volumes [3], [16]. But 
these methods needed yet to become more compact and versatile [16]. 
Second, with the cold war came the need of counteracting the threat of chemical and 
biological weapons [16]. The Defense Advanced Research Projects Agency (DARPA) supported 
a series of programs for the development of field-deployable microfluidic systems which could 
detect these threats [16]. This greatly stimulated for the rapid growth of academic microfluidic 
technology [16]. 
Third, came the pushing force of molecular biology [16]. With the 1980s explosion of 
genomics, as well as the advent of other areas of microanalysis related to molecular biology, 
came the need analytical methods with much greater throughput, which could achieve higher 
sensitivity and resolution [16].  
Fourth came the contribution of microelectronics [16]. The concept of microelectronics 
started around 60 years ago [4]; it inspired the ideal of miniaturization along with integration and 
automatization for providing parallelism, enhanced speed, portability, and reduced consumption 
of sample [4]. In microfluidics, electrons are conceptually replaced by the innumerable amount 
of chemical species, and the electrical wires by miniaturized pipes [4]. Another great 
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contribution from the microelectronics is the development of technologies such as 
photolithography [4].  
The interest of the academic research community in microfabricated microfluidic systems 
started in the mid-eighties, and has been growing steadily since then [4]. Some of the first work 
in microfluidics used silicon and glass, but neither of them where the most appropriate for the 
analysis of biological samples [16]. Elastomers such as poly(dimethylsiloxane) allow for a much 
easier fabrication process [16].  
The appearance of micropumps and valves was consequence of the need of a more 
precise control of liquid for advanced analysis applications [3], [18]–[20]. Pioneer work on 
miniaturized total chemical analysis systems (µTAS) was done by Manz et al. (1990) and led to 
the development of microfluidic high-pressure liquid chromatography systems as well as 
microfluidic capillary electrophoresis (1992) [3], [21]–[23].  
Following research in academia, early microfluidic life science companies such as 
Caliper Life Sciences (1995), and Cepheid (1996) appeared, and Hewlett Packard started 
producing gas chromatography, capillary electrophoresis, and high-pressure liquid 
chromatography systems for laboratories and miniaturizing analytical equipment [3]; these 
companies were pioneers in the commercialization of these types of systems [3].  
2.2 State-of-Art Development 
 
The ability to understand and diagnose disease has experienced a great progress over the 
past decades due to the advances in the quantification of molecular biomarkers [24]. Techniques 
such as genetic sequencing, mass spectrometry, flow cytometry, and nuclear magnetic resonance 
have allowed for higher sensitivity, promising improvements in early diagnosis, accurate 
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monitoring of existing diseases, and understanding of the underlying causes and mechanisms of 
disease. However, these techniques are highly complex, and therefore expensive, and they 
require special infrastructure, and a high degree of training [24]. POC testing is one of the most 
promising applications of microfluidics, since they can be performed by a clinician, or directly 
by the patient, without the need of a clinical lab, and with easy handling [24], [25]. Key 
requirements for a POC device include its ease of use, robustness of reagents and consumables in 
storage and usage, results concordant with established laboratory methods, and being safe to use 
[23]. The degree of integration of a microfluidic technology can vary from having disposable 
microfluidic chips that work in conjunction with peripheral equipment (active microfluidic 
systems), to having all functions needed for flow initiation and control, sample processing and 
analysis, and reporting the results on a chip (passive based microfluidic systems) [25].  
POC diagnostics have been available for many years, and have proven very beneficial 
[24]; their success has motivated the research and development of more complex chips where 
entire laboratory procedures can be performed [24]. The earliest POC tests focused on glucose 
detection, and they were based on tablets containing the test reagents [26]. Technological 
advances led to the development of dipstick devices, which evolved in time to self-contained 
LFD (e.g., for the detection of pregnancy, cardiac disease, and HIV-1 biomarkers) [26]. After 
years of evolution, current POC devices combine advances in electronics, photonics, 
microelectromechanical systems (MEMS), and microfluidics to build small, low cost chips that 
have a unique capability to perform full laboratory procedures in a portable device (lab-on-a-chip) 
[24], [26]. Microfluidic devices for POC applications differ from conventional microfluidics in 
their simplicity of use, and little or no use auxiliary external equipment [26]. 
In what follows some of the advances in the field of POC for health applications are discussed. 
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2.2.1 Current Context of POC Assays 
 
A number of clinical specimens (e.g., whole blood, sera, saliva, urine, and cerebrospinal 
fluid) contain free-floating biomarkers that can be used for the diagnosis and monitoring of 
diseases [27], [28]. Immunoassays are one of the most widely used biomarker sensing techniques 
that are adapted for point-of-care microfluidic-based diagnostics [24], [29]. Current biosensor 
formats aimed at disease biomarker detection use some form of immunoassay [29]. 
Immunoassays rely on the binding interactions between antigens and antigen specific antibodies 
to detect biological markers from either pathogen or host immune responses [24], [29]. The 
monomer antibodies used for immunoassay purposes possess ‘Y’ shaped structure, which 
contain two antigen binding sites [29]. The recognition site of a target antigen by a specific 
antibody binding site is called epitope, and even though antigens contain numerous epitopes, the 
binding of an antibody to a unique epitope is highly specific, making immunoassays a highly 
repeatable and highly specific reaction format [29]. Target biomarkers span the entire range of 
pathogen types, from viruses (e.g., HIV, Avian Influenza, Papillomavirus, Dengue, and Hepatitis) 
to bacteria (e.g., tuberculosis) and parasites (e.g., African trypanosomiasis, malaria). 
Immunoassays are also commonly used for detection of noncommunicable diseases (e.g., 
cardiovascular diseases, cancer [30]–[37], diabetes) [24]. 
POC microfluidic platforms have been manufactured using a wide range of materials, 
including glass, polydimethylsiloxane (PDMS), poly(methyl methacrylate) (PMMA), poly(cyclic 
olefin), paper, and combinations of the previous [38]. 




In chemiluminescence, the emission of light is triggered by a chemical reaction resulting 
from target binding [39]. This methodology is convenient for POC application because it doesn’t 
require excitation light sources and emission filters (which is the case for fluorescence based 
methods) [39]. Chemiluminescent microfluidic biosensors have been used for a variety of 
applications, including the quantification of glycated hemoglobin (Figure 2-1) [40]–[43], and the 
study of biomarkers for the diagnosis of Hepatocellular Carcinoma [44] and treatment 
monitoring of Leukemia [45]. 
 
Figure 2-1 Microfluidic platform developed by Ko-Wei Chang et al. for the quantification of 
glycated hemoglobin (Hb A1C) using an aptamer-based sandwich assay. (a) A schematic 
illustration of the trilayer microfluidic chip composed of micro-components, including normally-
closed valves, a transport unit (a closed chamber), a waste chamber and five open chambers; (b) 
a photograph of the microfluidic chip with dimensions of 28 mm×30 mm. Note that the red 
region and blue region represent the liquid layer and the air layer, respectively; (c) an exploded 
view of the microfluidic chip, which is composed of a thick-film PDMS layer for the air 
channels, a thin-film PDMS layer for the liquid channels, and a glass substrate; (d) a schematic 
diagram of five open chambers on the microfluidic chip for loading samples and reagents [40], 
[41].  




In electrochemiluminiscence (ECL), luminescence occurs as result of electrochemical 
reactions triggered and controlled by a set of electrodes [39]. ECL has several advantages for 
POC application, including its versatility and simple optical setup (compared to 
photoluminescence), its good temporal and spatial control (compared with chemiluminescence), 
and its negligible background signal [39]. One of the applications of ECL microfluidic 
biosensors is the study different types of cancer, including ovarian cancer [35], prostate cancer 
(Figure 2-2) [36], and Colorectal Carcinoma [34]. 
 
Figure 2-2 Design of microfluidic electrochemiluminescence (ECL) array for sensitive 
measurements of prostate specific antigen (PSA) and interleukin-6 (IL-6) in serum. The different 
components of the microfluidic platform are identified as following: 1) syringe pump 2) injector 
valve, 3) switch valve to guide the sample to the desired channel, 4) tubing for inlet, 5) outlet, 6) 
poly(methylmethacrylate) (PMMA) plate, 7) Pt counter wire, 8) Ag/AgCl reference wire (wires 
are on the underside of PMMA plate), 9) polydimethylsiloxane (PDMS) channels, 10) pyrolytic 
graphite chip (PG) (2.5 cm × 2.5 cm) (black), surrounded by hydrophobic polymer (white) to 
make microwells. Bottoms of microwells (red rectangles) contain primary antibody-decorated 
SWCNT forests, 11) ECL label containing RuBPY-silica nanoparticles with cognate secondary 
antibodies are injected to the capture protein analytes previously bound to cognate primary 
antibodies. ECL is detected with a CCD camera [36]. 




Fluorescence remains one of the most widely used methods for detection thanks to the 
availability of highly sensitive and selective fluorescence labeling techniques [39]. Fluorescent 
dyes are composed of small molecules, proteins, or quantum dots, which emit a photon when 
exited [39]. The limitation of flurescent methods lies in its need of more complex optical 
detection systems compared to colorimetric methods for example [39]. Fluorescence-based 
microfluidic biosensors have been used in applycations such as glycated hemoglobin 
quantification (Figure 2-3) [40], point-of-care testing in case of an exposure/intoxication to 
biological toxins [46], recognition of dengue virus (Figure 2-4) [46]–[48], detection of Neisseria 
meningitidis bacteria [49], detection of avian influenza H5N1 virus [50], and assessment of 
colorectal carcinoma biomarkers (Figure 2-5) [51]. 
 
Figure 2-3 Microfluidic platform developed by Ko-Wei Chang et al. for the quantification of Hb 
A1C using a dual aptamer method in lieu of antibodies. (a) Schematic illustration of the chip and 
its respective components, including six normally-closed valves, two transport unit (closed 
chamber), a waste outlet, and six open chambers. (b) Photograph of the 43mm×53 mm 
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microfluidic chip. The red and blue regions represent the liquid and air layers, respectively. (c) 
Exposed view of the microfluidic chip, which was composed of a thick-film PDMS layer for air 
control, a thin-film PDMS layer for the liquid channels, and a glass substrate. (d) Schematic 
diagram of the six open chambers on the microfluidic chip for loading samples and reagents [40]. 
 
Figure 2-4 Magnetic bead-based microfluidic chip designed by Fang Lee et al. for the analysis of 
dengue associated antibodies in human plasma. (a) A photograph of the microfluidic chip, 
comprising one and two-way micropumps, a four-membrane type micromixer, and an on-chip 
microcoil array. The dimensions of this chip are measured to be 53mm × 37mm. (b-1) A 
schematic diagram of the four-membrane-type micromixer; (b-2)–(b-5) show the motion of the 




Figure 2-5 Microfluidic protein chip for an ultrasensitive and multiplexed assay of cancer 
biomarkers in human serum, in the format of both sandwich and reverse phase immunoassay. (a) 
Schematic illustration of the microchannel network. (1) First, a PDMS piece was placed in a 
silyated slide; (2) The solutions were flowed through the channels, and the first layer of protein 
was immobilized; (3) The first PDMS piece was removed; (4) The other PDMS piece was placed 
on the substrate with channels perpendicular to the first PDMS piece; (5) Other solutions were 
flowed; (6) A two dimensional array was formed above the chip. (b) Schematic illustration of a 
sandwich immunoassay and reverse phase immunoassay based on CdTe/CdS quantum dots-IgG 
fluorescent probes and microfluidic protein chip [51]. 
2.2.1.4 Point of Care Electrochemical Biosensors  
 
Electrochemical methods take advantage of the interaction of chemical species with 
electrodes or probes to obtain electrical signals, allowing for the quantification of target analytes 
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present in the sample [39]. Electrochemical events can occur in two different orders, the first 
possibility is that the chemical reaction is triggered by  passing an electrical current through the 
electrode system, the second is that the electrode responses are triggered by specific chemical 
reactions such as oxidation and reduction [39]. Applications of electrochemical microfluidic 
sensors include the diagnosis of tumor biomarkers (2-6) [33], and coagulation status monitoring 
[53]. 
 
Figure 2-6 The schematic representation of microfluidic paper-based three-dimensional 
electrochemical device, developed by Wang et al. for the simultaneous diagnosis of two tumor 
markers: cancer antigen 125 and carcinoembryonic antigen. (A): Wax-patterned paper sheet; (B): 
the 3D--µPED, (a) paper working zones; (b) paper auxiliary zone. (C): Screen-printed electrodes, 
(c) carbon working electrodes; (d) Ag/AgCl reference electrode; (e) carbon counter electrode; (f) 
silver conductive channel and pad; (g) transparent polyethylene terephthalate substrate. (D): 
After stacking, the paper working zones and the paper auxiliary zone will be aligned to the 
screen-printed working electrodes, counter and reference electrode, respectively [33]. 
2.2.1.5 Point of Care Surface Acoustic Wave (SAW) Biosensors  
 
Surface acoustic wave biosensors rely on the modulation of surface acoustic waves to 
sense a physical phenomenon. In general, this devices generate and detect acoustic waves using 
interdigital transducers on the surface of a piezoelectric crystal [54]. SAW microfluidic 




Figure 2-7 PDMS microfluidic chip coupled with Love Wave sensor. (b) Picture of the PDMS 
microfluidic chip. (c) Schematic of the circuit for Love Wave sensor measurement. (c) Printed 
circuit board [55]. 
2.2.1.6 Point of Care Colorimetric Biosensors  
 
Colorimetric biosensors take advantage of the color change caused by 
chemical/biochemical reactions between the target analytes and the colorimetric probes [39], 
[57]. The advantage of this methodology for POC application lies in the ability of observing 
results with the naked eye, thus eliminating the need for bulky external detection systems [39], 
[58]. One of the most well-known colorimetric biosensors is the hCG pregnancy test strip [59], 
[60], however, these colorimetric biosensors have also been used for other applications such as 
multiplexing detection of Hepatitis B biomarkers (Figure 2-8) [61], human immunodeficiency 




Figure 2-8 Modified PDMS microfluidic ELISA device for the multiplexing detection of IL-5, 
HBsAg, and IgG in human serum. The microfluidic device encompassed several microchannels 
to guide the flow to a detection well, and then drain out to the waste outlet manifold by overflow, 
in such a way that backflow of the reacted fluid is eliminated, in order to avoid contamination. (a) 
Top view, (b) Section view of microfluidic ELISA device [61]. 
 
Figure 2-9 Schematic diagram and pictures of microfluidic device, and data on fluid handling of 
a POC ELISA-like assay for the simultaneous diagnosis of HIV and syphilis. (a) Picture of 
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microfluidic chip. Each chip can accommodate seven samples (one per channel), with molded 
holes for coupling of reagent-loaded tubes. (b) Scanning electron microscope image of a cross-
section of microchannels, made of injection-molded plastic. Scale bar, 500 µm. (c) Transmitted 
light micrograph of channel meanders. Scale bar, 1 mm. (d) Schematic diagram of passive 
delivery of multiple reagents, which requires no moving parts on-chip. A preloaded sequence of 
reagents passes over a series of four detection zones, each characterized by dense meanders 
coated with capture proteins, before exiting the chip to a disposable syringe used to generate a 
vacuum for fluid actuation. (e) Illustration of biochemical reactions in detection zones at 
different immunoassay steps. The reduction of silver ions on gold nanoparticle–conjugated 
antibodies yields signals that can be read with low-cost optics (for quantification) or examined 
by eye. (f) Absorbance traces of a complete HIV-syphilis duplex test as reagent plugs pass 
through detection zones. High optical density (OD) is observed when air spacers pass through 
the detection zones, owing to increased refraction of light compared to in the liquid filled 
channels. The train of reagents mimics the pipetting of reagents in and out of multiwall plates. 
This sample was evaluated (correctly against a reference standard) as HIV negative and syphilis 
positive. Ag, antigen [62]. 
2.2.1.7 Point of Care Localized Surface Plasmon Resonance Biosensors  
 
Localized surface plasmon resonance (LSPR) optical phenomena is generated by the 
interaction of light resulting with conductive nanoparticles with a smaller size than the incident 
wavelength [65]. The electric field of incident light is used to excite electrons of a conduction 
band, resulting in coherent localized plasmon oscillations with a resonant frequency strongly 
dependant on the composition, size, geometry, dielectric environment and separation distance of 
the gold nanoparticles [65]. Localized Surface Plasmon Resonance Biosensors have been used  in the 




Figure 2-10 Nanobiosensor based on localized surface plasmon resonance (LSPR) for the 
detection of microalbuminuria. The principle (left) and technologies developed (right) for 
forming the LSPR POC system [37]. 
Table 2-1 further summarized state of the art of POC microfluidic platforms for 
biomarker detection [38]. 
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While the development of microfluidic technology for diagnostics and disease monitoring 
has evolved rapidly over  the past years, to this date, these technologies still face several 
challenges for becoming truly viable for POCT [27]. For one, many of the technologies available 
still require some degree of training for handling the device, sample treatment, and even 
expensive external equipment for flow initiation and control as well as detection, and do not 
meet the portability requirement, which are all great limitations especially for low-resource 
settings. Detection methods like colorimetry are simple and low cost, however, they might not be 
as sensitive and somewhat compromise quantitation [39]. Other significant challenges remain in 
working with human sample matrices [27]. Also, each different human sample type and each 
disease biomarker require special assay development [27]; it is very complex to recreate a 
versatile platform which can be used with a broad spectrum of input species or clinical patient 
samples [27]. 
2.4 Chapter Summary 
 
In summary, a number of microfluidic platforms have been developed for the rapid 
detection of disease biomarkers, using materials ranging from paper to polymers and hybrid 
materials [39]. Some of these platforms are designed to perform individual steps, and can only be 
used to test human serum and not whole blood, but the critical challenge is to integrate these 
steps into a sensitive and selective integrated device that meets all the POC requirements 
including portability, low cost, and ease of handling [27]. To date only a small number of 
devices that offer total analysis on chip, including reagent storage, and sample collection and 
preparation, or the ability to test crude real-world samples (e.g. blood, urine, and saliva) [39], 
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[67]–[69]. The microfluidics community is in need of integrated POC solutions that can be used 
not only in research laboratory settings, but can also be delivered directly to patients. These 
integrated POC solutions would help bridge the healthcare gap between developed and 




Chapter 3 Capillary Systems Theory 
3.1 Capillary Phenomena  
 
Capillary phenomena designate the forces produced by interfacial tensions (N/m) at the 
interface of at least two immiscible phases, and the spontaneous transformation and dissipation 
of the interfacial energy into motion of a liquid [4], [71], [72]. These effects become 
predominant at small scales, where the forces exerted by the molecules at the interface surpass 
the forces arising from the molecules in the bulk [4]. Even though significant only at micrometer 
scales, capillary phenomena forms part of our everyday life [4]. 
Capillarity has been studied since da Vinci’s time [71].  Leonardo da Vinci’s observation 
of the capillary rise of liquid in tubes was the first recorded observation of capillary action [71]. 
In his book of 1759, Giovani Batista Clemente Nelli describes that a former student of Galileo, 
Niccolo Aggiunti (1600-1635), had also studied capillary action in mosquitoes, butterflies, and 
bees feeding [73]. Other studies soon followed [74]–[79]. Mathematicians Honoré Fabri and 
Jacob Bernoulli thought that liquids rose in capillaries because air couldn't enter capillaries as 
easily as liquids, so the air pressure was lower inside capillaries [80], [81]. Other scholars like 
Isaac Vossius, Giovanni Alfonso Borelli, Louis Carré, Francis Hauksbee, and Josia Weitbrecht 
thought that the particles of liquid were attracted to each other and to the walls of the capillary 
[82]–[89]. It took until 1805, for two investigators, Thomas Young and Pierre-Simon Laplace, to 
successfully quantify capillary action [90], [91]; they derived the Young-Laplace Equation of 
capillary action. Carl Friedrich Gauss then determined the boundary conditions governing 
capillary action in 1830 [92]. The effect of the meniscus on a liquid's vapor pressure, and the 
interaction between two immiscible liquids were determined by William Thomson and Franz 
Ernst Neumann respectively [93], [94]. 
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3.1.1 Wetting and Interfacial Free Energy 
 
When a small drop of liquid is put onto a flat solid surface, two distinct outcomes, 
representative of two different equilibrium regimes can occur [95], [96]. The first is partial 
wetting, where the liquid drop has a finite contact angle α with the surface; the second is total 
wetting, where the liquid spreads out as a thin molecular film [4]. The magnitudes of the free 
energy per unit area (J/m
2
) of each interface can be related via the contact angle α of the liquid to 
the surface, using Young’s equation [4]. 
𝛾𝐿𝑉 ∗ cos(𝛼) = 𝛾𝑆𝑉−𝛾𝑆𝐿  ( 1 ) 
Where γLV, SV, SL are free energy per unit area of the liquid-gas, solid-gas, and solid-liquid 
interfaces respectively (Figure 3-1) [4].  
  
Figure 3-1 (a) Surface tension forces at the three-phase line on a non-deformable solid surface 
[97]. 
If the boundary between wettable and non-wettable is 90º [4]; a surface is wettable when 
the magnitude of the contact angle is lower than 90º, and non-wettable if the contact angle is 
greater than  90º [4]. For the case of water, the wettability can be defined as hydrophilicity (α‹90º) 
and hydrophobicity (α›90º) [4]. 
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3.1.2 Dynamics of capillary flow in a microchannel 
 
In autonomous capillary systems (CSs) liquids are displaced by means of capillarity [98]. 
Their proper functioning requires displacing accurate volumes of liquids with precise flow rates 
[98]. The flow velocity of a liquid in a conduit can be derived from solving the Navier−Stokes 
equations [4].  
The flow rate of a liquid is a function of the viscosity of the fluid, the capillary pressure, 
and the total flow resistance of the flow path (governed by the device’s geometry), and can be 







  ( 2 ) 
where η is the viscosity of the fluid, RF is the total resistance of the flow path, and ΔP is 
the differential pressure between inlet and outlet, L is the length, A the area, and 𝑅𝐻  is the 
hydraulic radius of the microchannel (Equation 5). During filling by capillary action ΔP can be 
replaced with the pressure generated at the liquid meniscus, or capillary pressure (Pc) [4], [98]. 
The geometric and constant parameters can be regrouped for convenience into a unique 
parameter that we call the total flow-rate resistance, resulting in a simplified equation for flow 













  ( 3 )  
 
The total flow rate resistance (RF) of the flow path for a rectangular microchannel is not 
trivial to calculate, but it can be approximated by a linear term as long as 𝑎 < 𝑏 (Equation 4) [4], 
[100]. 


















  ( 5 )  
 
Where a and b are the depth and width of microchannel respectively [4], [98]. When 
filling the microchannel due to capillary action, the parameter L corresponds to the filled length 
of the channel, consequently, it increases with the advancement of the filling front of the liquid 
in the channel [4]. For a system with varying cross-sections connected in series, the total RF of 
the system can be calculated as the sum of the different components with constant cross-sections 
[4]. 
3.1.2.1 Capillary Pressure 
 
The capillary pressure (Pc) is the difference in pressure across the interface between two 
immiscible fluids, in this case plasma and air, and can be described by the Young-Laplace 
equation [4]. For a microchannel with a rectangular cross section, the curvature along the depth 
and width axes contributes to the meniscus pressure [4]. Pc  can then be calculated using 
Equation 6 [4], [101]. 






   ( 6 )  
where γ is the surface tension of liquid, and αb,t,l,r are the contact angles of the liquid on 
the bottom, top, left, and right wall of the microchannel respectively. The dynamic contact angles 
of the liquid with the walls of the microchannel depend on the speed of flow, as well as the 
receding or advancing state of the interface [4]. 
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When  using the static contact angles of the liquid with the substrate to calculate Pc, the 
four contact angles are assumed to be equal in magnitude, simplifying the calculation (Equations 
7-9). 

















  ( 9 ) 
 
Where RHeight and RWidth are the minor and mayor radii of curvature respectively, and α is 
the static contact angle. 
3.1.2.2 Viscosity 
 
Viscosity can be thought of as a measure of fluid friction: the greater the viscosity, the 
greater its resistance to flow [102]. More formally, it is a measure of its resistance to deformation 
by shear or tensile stress arising from the collision between neighboring particles in a fluid, 
moving at different velocities [50]–[52]. For Newtonian fluids (e.g blood plasma), its magnitude 
can be calculated as the ratio of the shearing stress to the velocity gradient in a fluid [4], [102]–
[104]. For the case of Non-Newtonian fluids (e.g blood), the relationship between shear stress 
and the velocity gradient is no longer linear, and therefore requires more complex calculations 
[102].  
Viscosity is mainly a function of the material, but it also varies with temperature: 
increased temperature will result in less viscous fluids [102], [103]; this occurs because as 
temperature increases, the average speed of the molecules in the liquid increases as well, 
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resulting in a reduction of intermolecular forces [103]. However, in this thesis the temperature is 
assumed to be constant during the operation of microfluidic devices [102]. 
The behavior of whole blood is that of a non-Newtonian fluid, meaning that its viscosity 
is dependent on shear rate (shear thinning or thickening) [105]. Shear rate is a function of the 
blood flow velocity, and as a result, when blood moves quickly (e.g. peak-systole), the shear is 
high and the blood is thinner, and when it moves slowly (e.g. end-diastole), the shear is lower, 
and blood becomes thicker due to red blood cell aggregation [105]. In conclusion, the viscosity 
of blood dynamically changes during each cardiac cycle [105]. 
On the other hand, serum and plasma are Newtonian fluids, so their viscosity does not 
change with the flow velocity, and therefore it is easier to measure [105], [106]. The viscosity of 
plasma is determined by its water-content and macromolecular components [106]. Since plasma 
is a highly concentrated protein solution, the proteins will have an effect in its viscosity  based on 
their molecular weight and structure [106]; higher molecular weights will result in higher 
aggregating capacity, and together with their sensitivity to higher temperatures or pH, will result 
in higher plasma viscosity values [106]. Normal plasma viscosity ranges between 1.10 and 1.30 
mPa∙s at 37°C, however, alterations might occur due to pathologies that cause inflammations (e.g. 
rheumatoid arthritis), tissue injuries,  unstable angina pectoris and stroke, and sometimes their 
higher values are associated with the progression of the disease and  higher rate of major adverse 
clinical events [106]. 
For the purpose of our study, the viscosity of both Phosphate-buffered saline (PBS) and 
plasma was measured with the aid of a viscometer at room temperature, and the values were 
found to be 1.04 and 1.66 mPa∙s respectively. The measured value for the viscosity of PBS is 
comparable to reported by Fluxion Biosciences [107]. However, the measured value for the 
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viscosity of human blood plasma is slightly higher than normal levels, which can be consequence 
of pathologies, inflammations, amongst others [106]. 
3.1.2.3 Hagen-Poiseuille’s Law 
 
In fluid dynamics, the Bernouilli’s equation is an application of the law of conservation 
of mechanical energy to a moving fluid [108]. This is the simplest model for the flow of a fluid 
through a channel [108]; however, it assumes that the fluid is incompressible and that there is no 
friction effect on it as it moves in the channel, which is not the case in microfluidics [108].  
The Hagen-Poiseuille equation describes a physical law that relates the pressure drop in 
an incompressible, Newtonian fluid flowing in the laminar regime  through a channel with 
constant cross-section (no acceleration) [102]. All which are characteristic of microfluidic 
systems [102].  
Ideally, Hagen-Poiseuille’s law applies for perfectly straight and infinitely long channels 
[102]; however, it can be used as a reasonable estimate for channels with finite length (L) as long 
as L is the prevalent dimension of the geometry [102]. 
3.1.2.4 Analogy Between Fluidic and Electric Circuit 
 
The behavior of fluids in channel networks  has a great resemblance with currents in 





  ( 10 ) 
Where ρE is the resistivity of the conductor in ohm, LE is the length of the conductor in 




The voltage (V) across the conducting material can be calculated using Ohm’s law, which 
says that V is equal to the current (I) flowing through the conductor times RE. Ohm’s law finds 
its fluidic counterpart in Hagen-Poiseuille’s law, which is described by Equation 11 as follows: 
𝛥𝑝 = 𝑅ℎ ∗ 𝑄  ( 11 ) 
Where Δp is the pressure drop across the microchannel in Pa, Q the volumetric flow rate 
in m
3
/s, and Rh the hydraulic resistance in Pa*s/ m
3
 [102]. The hydraulic resistance of a 




  ( 12 ) 
Where LC is the length of the channel in meter, a and b are the depth and width of 
microchannel respectively in meter, and ΠG is a dimensionless parameter defined as: 
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In a similar way to electric resistors, for N fluidic resistors (microfluidic channels) 
arranged in series, an equivalent single fluidic resistor has a hydraulic resistance equal to the sum 
of the N hydraulic resistances, because each resistor is carrying the same volumetric flow from 
one end to the other [102]. For parallel connected fluidic resistors the equivalent single fluidic 
resistor has a hydraulic resistance equal to the reciprocal of the sum of reciprocals of each 
hydraulic resistance [102]. 
German physicist Gustav Kirchhoff greatly contributed to the understanding of electric 
circuits by stating two fundamental laws [110]. The first law is commonly called Kirchhoff’s 
current law (KCL), and it says that at any point of the electric circuit, the sum of the currents 
flowing towards a node is equivalent to the sum of currents flowing out of the node [110]. This 
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law has a counterpart in fluidic circuits: the conservation of mass, which states that the sum of 
the flows into a node should be equal to the sum of the flows leaving the node [102].  
 
In a similar way, the second law (Kirchhoff’s voltage law) also has a counterpart in   
fluidic networks, which implies that the sum of each pressure drop along the closed path is zero 
[102].   
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Microfluidic systems have the potential of significantly changing how modern biology is 
done, due to their unique ability of integrating entire laboratory procedures onto a single chip 
[111]. These systems comprise a series of different basic components in order to perform the 
required functionality and the basic microfluidic operations [112], [113]. These basic 
components include: a method of introducing reagents and samples, methods for fluid transport, 
and a method for combination and mixing [113]. Some systems further extend their capabilities 
by integrating other components such as detection and in-chip sample processing [113]. 
Miniaturization leads onto the area of small Reynolds numbers, where fluid dynamics are 
very different from the macro scale, and different forces and effects dominate [111], [114]; the 
effects that become dominant in the micro scale fluidics include laminar flow, diffusion, fluidic 
resistance, surface area to volume ratio, and surface tension [111], [114]. Microfluidic systems 
should be designed in such a way that they take advantage of forces and effects that work on the 
micro scale [111].  
Here, we describe a strategy to initiate fluid flow by taking advantage of surface tension, 
control the rate of flow by modifying both the hydraulic resistance encoded by the flow resistor 
and modifying the PDMS surface properties by functionalizing it using Pluronic F127, separate 




4.2 Design of an Integrated Lateral Flow Device 
 
A lateral flow device (LFD) operated under the capillary force was designed for the detection 
of circulating biomarkers. The integrated LFD is composed of two layers, a bottom fluid layer 
and a top interfacing layer (Figure 4-1). The fluidic layer consists of a membrane-based plasma-
separation unit, a capillary pump (CP) for plasma extraction/delivery unit, a detection chamber, a 
flow resistor, and a second capillary pump for assisting fluid flow and waste collection. The 
interfacing layer consists of the reservoir for whole blood loading, an embedded pre-
functionalized glass substrate, and waste collection. The plasma separation membrane will be 
trimmed and put in a close contact with the microstructures in the 1
st








Figure 4-1 A) Schematic diagram of lateral flow device (LFD) for detection of single biomarker 
in whole blood sample. The first capillary pump (CP1) is partially covered by a GR plasma 
separation membrane, and it is designed for plasma extraction, while the second capillary pump 
(CP2) is designed to assist the fluid flow. Surface-immunoassays can be performed directly on 
the sealed chip by patterning capture antibodies on the gold chip placed on top of the detection 
chamber area. B) Schematic of assembled LFD. The black arrows indicate the flow direction. 
 
Ideally, the capillary pumps should generate smooth flow of the fluid in the capillary system 
(CS), filling the CS completely without entrapping air. Therefore the CP must have low flow 
resistance and high capillary pressure [98]. Advanced capillary pumping structures can further 
enhance the pumping capabilities of the CS [98]. The pioneer work for capillary pumping 
systems had been demontrated by Delamarche et al., in which the characteristic dimensions of 
the structures, width and spacing, affect the progression rates of the liquid in the vertical and 
horizontal directions [9], [98]. In our LFD, the 1
st
 CP for plasma extraction was designed with  
symmetric elongated structures (260 μm wide, 1041 μm long, and with a 260 μm spacing 
between structures) to control the filling front of the fluid, and 2
nd
 CP for assisting fluid flow and 
waste collection was designed with symmetric elongated microstructures as well (160 μm wide, 
640 μm long, and with a 160 μm spacing between structures). In capillary pumps with symmetric 




capillary pump, such as ours, there is a risk of entrapping air; symmetric structures reduce this 
risk since the filling fronts of liquid converge from the edges of the CP towards its center [98]. 
Accurate control of the flow is a key in providing enough time for protein binding to 
antibodies and biomarker detection; fluidic resistances of microchannels allow modulating the 
flow rate passively [115]. In our case, the resistance of fluid resistor was modified by means of 
varying the length of the flow resistor. Lengths studied ranged from 0.324 cm to 37 cm, while 
the width and depth of the channel were kept constant at 200 µm and approximately 20 µm 
respectively. 
4.3 Chapter Summary 
 
The novelty of this work lies in the high degree of flexibility and the integration of all 
functions required to perform a sandwich immunoassay through POC techniques. The LFD can 
separate human plasma from a droplet of whole blood, initiate and control the flow using a 
combination of resistance and surface modification techniques, and has the potential for 
detection of different biomarkers using a wide range of methodologies (e.g., colorimetric 
methods, fluorescence), all in a single chip. The LFD is portable, easy to handle, and low cost 








Materials dictate the properties of the microfluidic flow path in a large extent [3]; they 
influence flow rate, capillary pressure, wetting, optical properties, adhesion of biomolecules, 
cost, and the fabrication methods required [3]. Glass and silicon were the first generation 
microfluidics materials thanks to their capillary electrophoresis and solvent-involved 
applications; the downside to these materials is that they are expensive for microfabrication, and 
for the case of silicon, its opacity to visible and ultraviolet light, which present a limitation for 
conventional optical methods of detection [16]. Since then, a wide of materials and different 
fabrication techniques have been explored (Figure 5-1) [3], [116]. Elastomeric Polymer materials 
are widely used in microfluidics due to their ease of fabrication and surface modification, optical 
transparency to visible and UV light, biocompatibility, flexibility, low cost, and it can be used to 
pattern both planar and non-planar surfaces  [147], [149]; they also allow for complicated and 
parallel fluid manipulation [117]. Plastics are also rapid and inexpensive to microfabricate [117]; 
their broad variety makes them more flexible for different applications [117]. Hydrogels are 
highly permeable, so they allow for diffusion of molecules without bulk fluid flows [117]; they 
are non-toxic to cells, cost effective and commercially available [118]. Paper also presents a low-
cost, biocompatible, easy to use alternative, and it can be disposed after use [117]. Fluidic 
sample manipulation and biomarker detection can be performed in paper substrates thanks to the 
hydrophilicity of its fibers [119]; in addition, paper can be modified chemically to incorporate a 
wide variety of functional groups that can be covalently bound to proteins, DNA, or small 
molecules, and due to its white color it is a good medium for colorimetric tests, which makes 
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them a good option for point-of-care applications [120]. One of the drawbacks of paper-based 
microfluidic devices is the complex patterning of the channels on the chip [118]. These materials 
can also be combined into hybrid chips in order to exploit their complementing advantages [117], 
[121].  
 
Figure 5-1 Microfluidics are fabricated in a variety of materials, including glass, silicon, paper, 
elastomers like PDMS, hydrogels, thermoplastics, and thermosets. Fabrication processes differ in 
degrees of complexity, and therefore in cost. The selection of the material to be used will depend  
on several factors, including the application, the target audience, and the fabrication capabilities 
[117]. 
5.1.1.1 Capillary Systems Using Different Materials 
 
Silicon-based Microfluidics 
One of the advantages of using silicon in microfluidics it’s the capability to fabricate 
virtually any geometrical microstructure with high precision [122]. Silicon has high chemical 
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resistance, mechanical strength, temperature stability, and it benefits from well-established 
MEMS fabricating and integration processes [123]. However, as previously mentioned, this 
material is not optically transparent in the UV/ visible region, limiting detection capabilities, and 
it is also very costly to fabricate, which greatly limits its usage in low-income settings [122]. In 
addition, Silicon has a hydrophobic nature, so it needs to undergo treatments in order to become 
hydrophilic (e.g. chemical treatment to make silicon surface OH terminated) [124]. A widely 
accepted procedure for rendering silicon wafers hydrophilic is the RCA cleaning [124], [125]; 
RCA consist of an aqueous solution of ammonia and hydrogen peroxide [124]. 
Glass-based Microfluidics 
Glass has a good chemical resistance and it is very good for detection purposes thanks to 
its optical transparency, and its surface is hydrophilic in nature [122]. However, conventional 
glass capillary devices still have several limitations, including the complexity and cost of the 
fabrication methods [122], [126]. Recently, there has been some research on simplifying 
fabrication processes to overcome such limitations [126]–[128]. An example is the work of 
Benson et al., who developed a flow focusing glass capillary device based on commercially 
available chromatography components for easy assembly, disassembly, and cleaning [126]. 
Paper-based Microfluidics 
Paper is an attractive substrate for microfluidic applications due to its availability and low 
cost, biocompatibility, and its ability to transport liquids using capillary forces, without the need 
of external equipment [129]. The first report on paper-based microfluidics might be the work of  
Müller et al. in 1949 [129]; their work consisted of creating confined channels by patterning 
filter paper using paraffin barriers, for the study on the preferential elution of a mixture of 
pigments [129], [130]. Paper microfluidics field has rapidly grown since then [129]. 
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There are two types of “Lab-on-a-paper” devices for affordable disease diagnosis: The 
first consists of on demand devices, which are blank platforms that can be used for a variety of 
tests [129]. Upon the selection of the test to be performed, samples and reagents can be and 
added prior to the execution of the test [129]. The second consists of ready-to-use devices, which 
are test-specific, and already integrate the required reagents [129]. Most of the published works 
to date focus on the second type, since they are easier to handle by the patient [129]. Table 5-1 
lists the different analytes studied to date using “Lab-on-a-paper”technologies [129]. 
Table 5-1 Summary of the reported detection methods, example analytes and applications for 
both paper-based microfluidic devices and paper-based microarray plates [129]. 
 
Although paper-based microfluidic devices have many advantages, they too have several 
limitations, which are related to the material properties of paper, fabrication techniques, and 
detection methodologies [129]. One of the limitations is sample retention and sample 
evaporation during fluid transport, which result in only 50% or less of the total volume reaching 
the detection zones [129]. Another limitation is the strength of the hydrophobic barriers, as some 
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times it is not enough to withstand samples with low surface tension [129]. In addition, 
traditional detection methods have a high limit of the detection when integrated in paper 
substrates, making it problematic when analyzing samples of lower concentrations [129]. 
Polymer–based Microfluidics 
Polymers are widely used in microfluidics, and they possess several advantages including 
biocompatibility, low cost (in comparison to glass and silicon), and ease of fabrication using a 
diversity of techniques, and bonding [131]. Their chemical resistance, optical transparency, low 
autofluorescence, and absence of UV absorption capabilities can be compared to those of glass 
[122]. The variety of surface chemistries also allows the usage of different immobilization 
techniques for the antibodies and/or antigens [122]. However, polymers often require surface 
functionalization in order to acquire certain properties such as hydrophilicity [132]. A key 
elastomer in microfluidics is PDMS, thanks to its relatively low cost and ease of fabrication, the 
capability of modifying its surface to render it hydrophilic, the ability to reversibly and 
irreversibly bond to other materials including glass, plastic, and other PDMS pieces, its 
elasticity, amongst others [133]. In addition, micro-scale features can be reproduced with high 
precision, it is optically transparent down to 280 nm so it can be used with a large number of 
detection methodologies, it is nontoxic and can be cured at low temperatures, and can be bonded 
reversibly or irreversibly [131]. However, PDMS also has some drawback such as its absorption 
of small molecules, the leaching  of uncrosslinked oligomers, and the vapor permeability 
(evaporation effects can occur) [133]–[136]. Several surface modification methods have been 
used to overcome the hydrophobic nature limitation of PDMS [137]; such methods can be 
classified in three categories: gas-phase processing methods (e.g. plasma oxidation, ultraviolet 
(UV) irradiation, chemical vapor deposition (CVD) and sputter coating of metal compounds), 
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wet chemical methods (e.g. layer-by-layer (LBL) deposition, sol–-gel coatings, silanization, 
dynamic modification with surfactants and protein adsorption), and a combination of the 
previous [137]. 
In addition to PDMS, other polymeric materials have been used, including polycarbonate, 
polymethymethacrylate (PMMA), polystyrene, polypropylene, and PVC [122], [137]. 
Hybrids 
There is no optimal material for all microfluidic applications. The selection depends on 
the specific application. In this work, we decided to take advantage of the capabilities of 
different materials in order to make an integrated hybrid capillary microfluidic platform 
combining PDMS polymer, paper, and glass. This allowed us to perform plasma separation from 
whole blood, antibody immobilization for detection in the near future, and flow initiation and 
control using capillary forces. 
5.1.2 Method 
 
Polydimethylsiloxane (PDMS) is a clear, colorless silicon-based organic polymer, and it is 
the most popular material for microfluidic research and prototyping due to its ease of fabrication, 
biocompatibility, nontoxicity, optical transparency, and gas permeability. However, because of 
its hydrophobic nature and strong adsorption of biological molecules such as proteins, PDMS is 
not suitable to be directly used to fabrication devices used in analytical, biological, and clinical 
applications. In this work, PDMS was functionalized with Pluronic F127 to modify its 
hydrophobic surface for the LFD fabrication and operation. The molecules of pluronic have a 
triblock structure, consisting of one hydrophobic polypropylene oxide (PPO) group accompanied 
45 
 
by two hydrophilic polyethylene oxide (PEO) units [138]. The general structure is PEOn-PPOm-
PEOn, where m and n vary based on the type of pluronic (for pluronic F127, m=100, n=65, 
molecular weight=12600) [138], [139]. The PPO chain attaches to the hydrophobic polymer 
(PDMS), while the PEO chains self-assemble into a cilia-like surface on the PDMS, effectively 
repelling proteins [138], [140]. Pluronic copolymers are an important type of surfactants due to 
their low toxicity and immunogenic response; they are approved for medical applications by the 
US Food and Drug administration [138], [140]. 
The microchannels networks were fabricated using standard photolithography and soft 
lithography techniques [141]. The process consisted of utilizing a high-resolution photomask to 
expose and polymerize a polymer-based photoresist spun cast onto a silicon wafer [6]. Following 
development, the resulting three-dimensional (3D) structure was used as a template for 
replication in Pluronic F127 (Sigma-Aldrich Co.) functionalized PDMS (Sylgard 184). The 5 
mm by 10 mm glass chips where cut using a diamond tip, and the interfacing layer was then 
fabricated by placing the chips on a 10.16 cm by 10.16 cm petri dish, and casting the Pluronic 
functionalized PDMS on the dish, followed by degassing, and curing 1 hour at 60 ºC. The result 
consisted of a clean, flat Pluronic functionalized PDMS surface, with the glass chip embedded in 
it, which was then bonded to the PDMS replica (flow layer) to generate a sealed microfluidic 
network. 
SU-8 2025 negative photoresist (Microchem) was used for fabricating the fluidic layer mold. 
SU-8 2025 was spin coated on a silicon wafer to a thickness of 20 μm, exposed to UV radiation, 
and rinsed in SU-8 developing solution to create the microchannel templates. Channel height was 
then measured using a Stylus Profilometer. 
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200 mg of Pluronic F127 were dissolved in 1 mL of alcohol. Samples with 20 µL and 40 µL 
of this complex were mixed thoroughly with the freshly made uncured 10 g PDMS, resulting the 
final Pluronic concentration as 2 µL/g and 4 µL/g, respectively. The PDMS/Pluronic mixed 
solution was then cast over the SU-8 master mold creating an inverse replica of the design, and 
cured for one hour at 60 °C. Once cured, the PDMS/Pluronic layer was removed from the master 
mold. Inlets and outlets for the fluids were cut out from the interfacing layer using a sharpened 
puncher (Figure 5-2).  
 
Figure 5-2 Photograph of the fluidic microchannels 
In aqueous environments, the Pluronic migrates towards the surface due to the high gradient 
between the water and the PDMS substrate, resulting in a reduction of nonspecific adsorption 
and an enhancement of wetting [138], [139]; for this reason, both layers were immersed in 500 
mL de-ionized water for 24 h at room temperature. After the 24 h immersion, the surfaces of 
both the flow and the interfacing Pluronic functionalized PDMS layers were dried with nitrogen 
gas and then exposed to oxygen plasma treatment for 30 seconds. The flow layer was 
immediately placed in conformal contact with the interfacing layer, irreversibly bonding them 
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together, ensuring that the glass chip on the interfacing layer was placed directly on top of the 
detection chamber on the flow layer, and then stabilized in an oven at 60 °C for half an hour. 
5.2 Flow Rate Control 
5.2.1 Background 
 
Flow control is a key in the proper functioning of microfluidics devices, and it can be 
achieved by using a combination of valves, pumps, and resistances [3]. The overall flow rate of 
the fluid is encoded by the pumping mechanism, which can be either active (e.g. reciprocating 
movement membrane valve, capillary electrophoresis using electro-osmotic flow, centrifugal 
force in Lab on a CD devices, electro wetting) or passive (e.g. porous capillary membrane, 
capillary pump, vacuum driven suction) depending on the application requirements [3], [142]. 
5.2.1.1 Active Pumping 
 
These type of microfluidic systems require external macroscopic actuators such as 
syringe pumps, peristaltic pumps, air pressure pumps, multiport valves, sensors, and even 
computers for flow rate control [168], [178]–[180]. Flow can be driven by mechanical 
displacement, electrical fields, magnetic fields or centripetal force [3].   
Active pumping setups provide a higher degree of interactive control, and the allow for 
controlling liquids in a broad range of flow rates, pressures, viscosities, molecular weights and 
compositions, but at the expense of complexity, lack of portability, scaling, and cost [3], [4]; for 
this reason their main application is in research settings [3].  
Syringe pumps are frequently used in microfluidics due to their ease of use [3]. The 
working mechanism consists of a stepper motor which causes the syringe’s plunger to move at a 
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constant speed, encoding the desired flow rate, while small tubing connect the syringe to the 
microfluidic chip [3]. Microfabricated mechanical displacement pumps actuate a membrane or 
diaphragm in a reciprocating mode [3], [143], [144].  
Electro-osmotic pumping is based on a chemical equilibrium at the interface between a 
liquid and a solid, resulting in a charged surface and counter ions in the liquid [3]. When 
applying an electrical current, the counter ions will move with the electrical current, creating a 
pressure gradient and therefore flow of the liquid [3]. However, electro-osmotic pumping has 
some weaknesses, including the sensitivity to impurities that adsorb on the wall of the channel 
and to changes in composition of the buffer, ohmic generation of heat in the fluid, and the need 
for very high voltages and therefore macroscopic power supplies [4]. 
Another approach is the lab on a CD, where the liquid is loaded into a reservoir near to 
the disk’s center, and when the rotated at varying speeds, the liquid is pumped through the 
microfluidic channels thanks to centrifugal force [3]. 
Electrowetting devices apply pulses of electrical potentials between ground and actuation 
electrodes creating electrostatic and dielectrophoresis forces that temporarily change the wetting 
properties, rendering the surface hydrophilic, which allows for fluid flow [3]. 
Several alternate active pumping schemes has been reported in scientific literature [4]. 
5.2.1.2 Passive Pumping 
 
Flow rates in passive pumping are a function of the design.  Passive microfluidics uses 
chemical gradients on surfaces, osmotic pressure, permeation in PDMS, or capillary forces to 
drive the fluid through the microfluidic channels [3]. These systems have spontaneous filling and 
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present an attractive alternative due to their portability, zero power consumption, low volume 
requirement, low cost, and ease of handling [3]. However, these devices offer less flexibility of 
modification by the user. 
In capillary systems (CS), liquids are displaced by means of capillarity. Their proper 
functioning requires displacing accurate volumes of liquids with precise flow rates [98]. The 
capillary pressure is a function of the depth and width of the microchannels, the surface tension 
(γ) and contact angles with the bottom, top, left and right side walls [3]. The capillary resistance 
is a function of the geometry of the channel, and together with capillary pressure and viscosity of 
the fluid  (η), it can aid in calculating the flow rate [3]. Capillary pumps (CPs) encompass micro 
pillars of diverse shapes and dimensions, whose position in the capillary pump (CP) encodes the 
desired capillary pressure [98], and together with their shape, will determine the filling front of 
the liquid in the CP as well as the flow rate [98]. The high differential pressures created by the 
CPs allow for supplying near-constant continuous flow over the course of several minutes [8]. 
Berthier et al. investigated a microfluidic passive pumping method relying on surface tension, in 
which a small inlet drop was placed on the entrance of a microfluidic channel, creating higher 
pressure than that of a larger output drop at the channel exit, resulting in the flow of the fluid 
[145]. Other methods require an additional user induced pressure (manual pressure), such is the 
case of the control scheme developed by Vestad et al. by which capillary networks flow could be 
dynamically controlled through simple external pressure and membrane deflection [6]. 
Sometimes controlling more than one working fluid is necessary, for example for multiplexing 
biomarker detection or parallelization of miniaturized bio/chemical processes [9]; Junker et al. 
developed a CS that could autonomously transport aliquots of different liquids in sequence [9]. 
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Capillary driven microfluidics systems are low cost, easy to handle, and portable, so they 
are a good alternative for POC applications, however, they do present some challenges such as 
evaporation of liquid in loading pads, blocked channel due to debris or defects, and higher 
resistance with lower dimensions, which can be addressed with a proper design and 
manufacturing process [3]. 
5.2.2 Contact Angle Measurement 
 
To understand the effect of resistance variation, and Pluronic concentration in the PDMS, 
and verify the hydrophilicity of the surface, the static and dynamic contact angles of several 
samples were measured. Concentrations of 2 µL/g and 4 µL/g were taken into account 
(concentrations lower than 2 µL/g were also studied but the contact angle variation was very 
small, while concentrations higher than 4 µL/g turned out too cloudy, which could conflict with 
optical detection methods).  Because contact angles on the channel wall surfaces may be 
significantly different from smooth and flat surfaces [146], both the static and in-situ dynamic 
contact angles were measured and compared to study the wettability of PDMS surfaces 
with/without Pluronic functionalization. Static contact angle on the flat surface was measured 
using a handheld digital microscope (Celestron, LLC), by placing the microscope in horizontal 
position (parallel to the substrate), such that an image of the droplet outline and its reflection on 
the substrate could be taken; static contact angles were analyzed using Image J software (NIH). 
For the dynamic contact angle measurement, a drop of liquid (40µL) was placed in the inlet port 
of the LFD, and the air-liquid interface was recorded by performing a time-lapse imaging using a 
Nikon Eclipse Ti microscope, using objective lenses with a magnification from 4× to 20×. NIS-
Elements Viewer (Nikon Instruments Inc.) was then used for analysis. Experiments were 
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performed for both PBS and Human Blood plasma, on both water treated and Pluronic 
functionalized PDMS without water treatment. 
In addition, the dynamic contact angles were measured for all five flow resistors, in order 
to evaluate the relationship between the resistance and contact angle. For statistical analysis, data 
was presented as the mean ± standard derivation (SD) and each individual 
measurement/experiment was performed at least three times (n > 3). 
Note that in this work we describe two types of fluidic resistances. The first, total flow-
rate resistance is function of the geometry of the microchannels alone (Equation 4); while the 
second, hydraulic resistance, accounts for not only the geometric parameters but also the 
viscosity of the fluid flowing through the channels (Equation 10). Since the total flow-rate is 
only function of geometry and is independent of viscosity, its magnitude is equivalent for both 
PBS and Plasma for each individual flow resistor (Table 5-2). On the other hand, the magnitude 
of the Hydraulic resistance is always higher for plasma since its viscosity is greater than that of 
PBS (Table 5-2). 
Table 5-2 Total flow-rate resistance vs. Hydraulic resistance PBS  
Channel geometry Total flow-rate resistance (m
-3








Depth of the 
microchannel 
(μm) 
Width of the 
microchannel 
(μm) 
PBS Plasma PBS Plasma 












3 27.3 200 1.02E+17 1.02E+17 1.01E+14 1.61E+14 
10 25.1 200 4.35E+17 4.35E+17 4.28E+14 6.84E+14 
20 25 200 8.80 E+17 8.80 E+17 8.67E+14 1.38E+15 




5.2.3 Results  
5.2.3.1 Dynamic vs. Static Contact Angle Measurement 
 
Due to the hydrophobic nature of the PDMS, surface modification via functionalization 
with Pluronic F127 was necessary. The effects of the surface modification and the variation of 
the flow resistor’s resistance on the characteristics of the capillary flow were studied in five 
different microfluidic devices. Table 5-3 presents a summary of the parameters measured in this 
work. 
Table 5-3 Summary of measured parameters 
Contact 
angles 
Static PBS  Control 
 Pluronic Functionalized 
PDMS [2 µL/g] 
 Pluronic Functionalized 
PDMS [4 µL/g] 
 Water treated 
 Non Water 
treated  
Plasma 
Dynamic PBS  Pluronic Functionalized 
PDMS [2 µL/g] 
 Pluronic Functionalized 
PDMS [4 µL/g] 
 Water treated: 
partial 
immersion 
 Water treated: 
full immersion 
 Non Water 
treated 
Plasma 
Flow rate PBS Five different 
resistances 
 Pluronic Functionalized 
PDMS [2 µL/g] 
 Pluronic Functionalized 
PDMS [4 µL/g] 
 Water treated: 
partial 
immersion 





Static contact angles measured from smooth flat surfaces can greatly differ from in situ 
dynamic contact angles, and they do not account for the resistance encoded by the constricted 
microchannel and the structures in the capillary pumps (influenced by their shape, size, and 
spacing between structures). Static contact angles were measured by dispensing a droplet of 
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Plasma or PBS on the surface of the Pluronic functionalized PDMS (without water exposure). 
The angles were continuously monitored for a period of 20 minutes (Figure 5-3) [147]. As a 
point of comparison, dynamic contact angles were measured using Nikon Eclipse Ti microscope. 
For the flow resistor, dynamic contact angle measurements were always taken at the entrance 
channels for consistency. The inverted microscopy technique allowed for measuring only the top 
and bottom dynamic contact angles (αb and αt), however, side angles can be calculated using 
Equation 6. Static contact angle measurements where used in the flow equations in order to 
compare the theoretical and the experimental flow rate. 
 
Figure 5-3 Representative images showing the change of the static contact angles of a 10 μL 
droplet of plasma Pluronic functionalized PDMS [4 µL/g]. A) Initial contact angle just after 
dispensing the droplet. B) 5 min after dispensing the droplet. C) 10 min after dispensing the 
droplet. D) 15 min after dispensing the droplet. E) 20 min after dispensing the droplet. 
Table 5-4 Static contact angle without water treatment 
 Plasma 




Static contact angle (mean ±SD) 79.82°±3.91° 68.42°±5.22° 69.85°±1.30° 
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Static contact angles were measured for a continuous period of 20 minutes as to provide 
enough time for the droplet contact angle to stabilize [147]. The angles where originally 
hydrophobic, and the change from hydrophobic to hydrophilic occurred after 5 minutes [147]. 
Table 5-4 shows the magnitude of the stabilized static contact angle after 20 minutes. For the 
pluronic functionalized samples, the concentration of pluronic had a very small impact on the 
static contact angle. 
On the other hand, the pluronic concentration had a greater effect on the dynamic contact 
angle (Figures 5-4B and 5-4C). Dynamic contact angles proved more hydrophilic with increase 
in the concentration, however, the flow resistance proved the mayor influence in both the 
magnitude of the contact angles, and more importantly, the flow rate. The contact angle was 
measured for sets of identical microchannels, with the only difference being the concentration of 
the Pluronic in the PDMS. The contact angle proved to be reduced as concentration increased 
(Table 5-5). It is known that the pillar aspect ratio and their positioning in the capillary pumps, as 
well as and the physical properties of the fluid (e.g. surface tension, viscosity), have a great 
impact on the capillary phenomena in the microchannel [148], [149]; with this in mind contact 
angles were also measured in both the first and second capillary pumps. In a similar way to the 
flow resistor’s contact angles, the capillary pump’s contact angles had a tendency to decrease 
with higher concentrations of pluronic (Tables 5-6 and 5-7). The effect of the resistance, 
determined by the microstructures in the capillary pump, on the magnitude of the contact angle 
can be observed in Figure 5-5. The contact angle proved more hydrophilic for the CP2 than those 




Figure 5-4 A) Schematic of Dynamic contact angle in Flow Resistors.  The interface has concave 
contact lines for the side walls and nearly flat (90°) contact lines for the top and bottom walls; 
the contact lines with the top and bottom walls can also have a convex shape when the contact 
angle is greater than 90°. The light area represents the plasma phase, which moves from left to 
right. B) Highly hydrophilic microchannel (Pluronic/PDMS [4 µL/g]). C) Less hydrophilic 





Figure 5-5 Representative results showing the dynamic contact angles in the capillary pumps. A) 
CP1, Plasma, Pluronic functionalized PDMS (Pluronic/PDMS [4 µL/g]). B) CP2, plasma, 
Pluronic functionalized PDMS (Pluronic/PDMS [4 µL/g]). C) CP1, PBS, Pluronic functionalized 
PDMS (Pluronic/PDMS [2 µL/g]). D) CP2, Plasma, Pluronic functionalized PDMS 
(Pluronic/PDMS [2 µL/g]). The black arrows indicated the flow direction in the capillary pumps. 
 
Tables 5-5, 5-6, and 5-7 show that αb and αt measurements often tend to be close to 90° 
or larger; this occurs because the dynamic contact angle tends to increase rapidly in response to 
increased wetting speed [146], [150]. If the dynamic angles of the left and right side walls (αl and 
αr) were assumed to be equal to αb and αt, the capillary pressure would be zero or negative, 
resulting in a stationary interface or the interface moving in the opposite direction, which would 
contradict the observed experimental results [146]. The fact that the meniscus moved in the 
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positive implies that αl and αr are smaller than 90° [146]. Figure 5-4A shows the three-
dimensional schematic of the interface in the functionalized channels.  

























(no flow resistor) 
91.80°±1.83° 101.75°±8.03° 105.60°±3.07° 102.47°±2.54° 
1.02E+17 99.43°±3.50° 94.30°±5.21° 106.80°±4.66° 73.58°±15.67° 
4.35E+17 91.87°±1.96° 88.60°±11.78° 104.00°±1.00° 58.90°±4.96° 
8.80 E+17 101.00°±1.31° 63.25°±4.90° 108.26°±3.31° 95.45°±2.85° 
2.35 E+18 107.00°±8.07° 96.00°±8.48° 94.00°±3.67° 91.30°±1.67° 
 

































7.73E+15 98.17°±2.40° 107.89°±3.14° 107.50°±6.40° 96.75°±5.06° 
8.69E+15 104.50°±2.52° 94.75°±2.75° 117.20°±7.08° 91.50°±0.58° 
1.11E+16 95.75°±2.99° 90.42°±1.36° 97.50°±1.97 100.00°±2.21° 
1.13E+16 103.50°±2.08° 87.62°±2.43° 109.33°±6.03° 101.17°±5.60° 
1.64E+16 104.06°±1.93° 80.28°±2.87° 96.62°±2.87° 108.00° 
 
The left and right contact angles can be estimated by calculating the experimental flow 
rate for each component and using the equations in Section 3.1.2 to find the αl and αr that would 
encode that flow rate. 
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3.17E+16 93.67°±1.53° 93.06°±1.86° 95.12°±4.87° 103.00°±4.24° 
3.56E+16 90.00°±0.82° 84.67°±3.05° 81.00°±1.73° 57.25°±2.50° 
4.55E+16 28.40°±6.27° 44.62°±5.56° 71.50°±2.26° 53.37°±3.68° 
4.60E+16 78.17°±6.53° 42.86°±6.82° 81.00°±1.82° 70.25°±1.26° 
6.69E+16 91.92°±2.06° 32.00°±6.24° 102.80°±1.92° 44.31°±6.29° 
 
 
Figure 5-6 Dynamic contact angle in each functional unit of the device using a Pluronic/PDMS 
concentration of [2 µL/g] 
Contact angle in each function unit [2 µL/g] 
Total resistance of entire device (m
-3
)







































Figure 5-7 Dynamic contact angle in each functional unit of the device using a Pluronic/PDMS 
concentration of [4 µL/g] 
Figures 5-6 and 5-7 show the variation of the dynamic contact angle for each functional 
unit of the LFD, considering the change in resistance and in the concentration of pluronic. The 
dynamic contact angle is often lower for higher concentration of pluronic. In addition, the angle 
usually lowest in magnitude for the secondary capillary pump, as the wetting velocity is 
decreased as consequence of the additive resistance from all previous functional units (as these 
units are connected in series).  
5.2.3.2 Flow rate 
 
Flow rate was regulated by varying the dimensions of the microstructures in the capillary 
pump and the spacing between them, as well as the dimensions of the flow resistor, resulting in 
Contact angle in each function unit [4 µL/g] 
Total resistance of entire device (m
-3
)





































their resistance changes; this allowed for providing more time for the binding of proteins to 
antibodies, and detection. The capillary pumps determine the filling front of the system, and their 
resistance is highest when they are almost full; however, the resistance of capillary pumps is few 
orders of magnitude smaller than the total flow resistance of the capillary system.  In addition, 
the concentration of Pluronic also had to be optimized. In order to be able to predict the effect of 
the combination of the resistance and the Pluronic concentration on the flow speed, in-situ 
dynamic contact angle measurements were performed for different solutions, which were then 
compared with the time-lapse results. The concentration of Pluronic F127 and geometric flow 
resistances had great impact in the flow speed of the sample. Higher concentrations of Pluronic 
reduced the contact angle, therefore increasing the hydrophilicity of the device and allowing for 
higher flow rates. Longer flow resistors encoded a higher fluidic resistance therefore reducing 
the magnitude of the flow rate. Flow rate was measured by measuring the time required for the 
fluid to flow through each component of the CS. Table 5-8 shows the relationship between the 
flow rate of the flow resistor, the geometry based fluidic resistance, and the concentration of 
Pluronic. The highest flow rate (18.4 nL/s) achieved was for a device with no flow resistor 
(straight channel), and a pluronic concentration of 4μL/g; the lowest flow rate was achieved with 
a 37 cm long flow resistor (0.43 nL/s), and a concentration of 2μL/g. Flow rate is higher for PBS 
than Plasma due to its viscosity and surface tension.  
Time lapses using the Ti microscope were used to analyze how the flow rate decays over 
the length of the channel. Table 5-9 shows the flow rate of Plasma at the entrance of the flow 
resistor, and at the middle of the same for two devices. Even though the flow rate decays over the 
length of the resistor, the flow rate of the device with lower fluidic resistance is higher at all 
times. The decay in speed occurs not only due to viscous dissipation forces, but predominately 
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due to the increase in length of the filled length in the channel and the friction due to the bulk 
viscosity [4]. 
 
Table 5-8 Flow rate of entire flow resistor 
 
Flow rate of the entire flow resistor 
mean±SD (nL/s) 











 PBS Plasma PBS Plasma 
No flow resistor 9.20±0 18.4±0 18.40±0 18.40±0 
1.02 E+17 12.15±0.64 9.94±0.43 2.06±1.46 12.60±0 
4.35 E+17 4.08±0.60 3.17±0.46 3.12±0.90 2.37±0.18 
8.80 E+17 2.37±0.20 1.24±0.61 1.70±0.72 1.65±0.11 
2.35 E+18 1.20±0.07 0.43±0.10 0.98±0.06 0.52±0.01 
 
 
Figure 5-8 Relationship between the geometric resistance variation and the flow rate of plasma. 
Flow rate of entire flow resistor (Plasma)
Total resistance of flow resistor (m
-3
)

















Pluronic functionalized PDMS [2 µL/g]
Pluronic functionalized PDMS [4 µL/g]
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Note from Figure 5-8 the general tendency of flow rate to increase as the concentration of 
pluronic increases, as well as when the geometric resistance is reduced (which occurs at shorter 
lengths).  
Zimmerman et al. had previously reported studies on flow rate control taking advantage 
of the effect of the secondary capillary pump alone [149]. Their studies were only able to tune 
the flow in a very short range of velocities (0.2-3.7 nL/s) by modifying the dimensions and 
positioning of the micropillars in the capillary pumps [149]. Even though our work used a set of 
dimensions for each capillary pump, we took advantage of other factors, including the flow 
resistor resistance and the concentration of pluronic, and were able to increase this range from 
0.43 to 18.4 nL/s. As previously mentioned, time is a key variable for performing immunoassays 
using microfluidic technology, so widening the range of flow rates provides much flexibility, and 
the perfect setting for tuning the time for immunoassays in the future. 







Tables 5-10 and 5-11 show the relationship between the flow rate of the Capillary pumps, 
the geometry based fluidic resistance, and the concentration of Pluronic. Flow rate was highly 
consistent for CP1 due to the fact that a large portion consists of an open window where the 
plasma separation membrane is placed (Figure 5-9). The flow rate in CP2 had a general tendency 
to increase as resistance decreased and as concentration of pluronic increased (Figure 5-10).  












Plasma 4.35E+17 2.99±0.14 1.31±0.07 
8.80 E+17 1.93±0.32 0.71±0.06 
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Table 5-10 Flow rate in first capillary pump 
 
Flow rate of the first capillary pump 
mean±SD (nL/s) 
Resistance of the 











 PBS Plasma PBS Plasma 
7.73E+15 818.40±0 818.40±0 818.40±0 818.40 
8.69E+15 786.70±0 786.70±0 786.70±0 786.70±0 
1.11E+16 723.30±0 723.30±0 723.30±0 723.30 
1.13E+16 720.40 720.40±0 720.40 720.40±0 
1.64E+16 633.97±0 633.97±0 633.97±0 633.97±0 
 
 
Figure 5-9 Flow rate in first capillary pump 
Flow rate of first capillary pump
Total resistance of first capillary pump (m
-3
)
































Table 5-11 Flow rate in second capillary pump 
 
Flow rate of the second capillary pump 
mean±SD (nL/s) 
Resistance of the 











 PBS Plasma PBS Plasma 
3.17E+16 30.62 38.55±7.85 45.49±15.44 34.61±1.58 
3.56E+16 15.19±1.83 8.88±1.80 15.36±0.32 12.11±3.72 
4.55E+16 4.22±0.65 2.08±0.52 3.03±0.69 1.43±0.46 
4.60E+16 1.63±0.29 0.90±0  1.88±0.56 1.34±0.06 
6.69E+16 0.94±0.09 0.32 1.00±0.14 0.61±0.11 
 
 
Figure 5-10 Flow rate of secondary capillary pump 
5.2.3.3 Water Treatment 
 
Flow rate of second capillary pump
Total resistance of second capillary pump (m
-3
)


































As previously mentioned, the properties of the Pluronic in the PDMS where further 
enhanced by DI water treating the LFD in order to trigger the gradient-induced migration of the 
pluronic embedded in the PDMS. This treatment would further enhance the hydrophilic 
properties of the microfluidic channels, and it would also make the surface more stable and less 
prompt to nonspecific adsorption. Two methods where compared. The first consisted of fully 
immersing the LFD in DI water for 24 hours, and the second consisted in placing the patterned 
surface of the fluidic layer as well as the surface of the interfacing layer in contact with the DI 
water for the same 24 hours (Figure 5-11). Contact angles were measured using both methods, 
and proved to be much lower for the devices partially immersed in water compared to those fully 
immersed (Tables 5-16 and 5-17); flow rate was in consequence higher for the partially 
immersed devices. 
 
Figure 5-11 Schematic of process of surface modification. A) Before water treatment. B) Water 
treatment by full immersion. C) Water treatment by partial immersion. 
Flow rate was also measured and compared for devices with and without the water 
treatment, for both the entire device and the flow resistor portion (Tables 5-12 to 5-14).  Even 
though contact angles proved to be more hydrophilic (Figure 5-12), and flow rate was higher at 
the entrance of the channels, it was observed during experimentation that the effects of 
66 
 
evaporation where more evident in water treated devices, which resulted in the full length flow 
rate been lower compared to that of the non-treated ones. 
 
Figure 5-12 Contact angle of water treated (partially immersed) LFD at the flow resistor. The 
concentration of pluronic was 4 µL/g. The black arrow indicates the direction of the flow. 
Table 5-12 Flow rate of entire device without water treatment 



















  PBS Plasma PBS Plasma 
5.10 E+16 No flow 
resistor 
101.11±5.21 60.70±0.98 127.77±9.77 61.30±4.62 
1.49 E+17 1.02 E+17 29.32±1.18 18.88±2.27 32.18±1.10 27.76±8.16 
4.94 E+17 4.35 E+17 8.83±1.50 4.96±1.17 6.35±1.87 5.23±1.66 
9.40 E+17 8.80 E+17 3.61±0.32 2.02±0.05 3.59±1.44 2.86±0.19 




Table 5-13 Flow rate of entire device with water treatment 



















  Plasma Plasma 
5.10 E+16 No flow 
resistor 
56.72±6.35 31.79±5.69 
1.49 E+17 1.02 E+17 23.49±1.04 28.57±4.10 
4.94 E+17 4.35 E+17 3.84±1.27 3.13±0.24 
9.40 E+17 8.80 E+17 1.96±0.12 1.85±0.84 
2.44 E+18 2.35 E+18 1.48±0.09 1.62±0.38 
 
Figure 5-13 shows the effect of the resistance, the concentration of pluronic and the water 
treatment on the flow rate of the entire device. The resistance has the most impact on the flow 
rate.   
 
y = 1E+17x-0.923 




















Total resistance of entire device (m-3) 






y = 2E+20x-1.1 





















Total resistance of entire device (m-3) 
 Pluronic functionalized PDMS [4 µL/g]
Power ( Pluronic functionalized PDMS [4 µL/g])
y = 9E+18x-1.03 




















Total resistance of entire device (m^-3) 
Pluronic functionalized PDMS [2 µL/g]






Figure 5-13 Flow rate of the entire device. A) Pluronic Functionalized PDMS [2 µL/g] without 
water treartment. B) Pluronic Functionalized PDMS [4 µL/g] without water treartment. C) 
Pluronic Functionalized PDMS [2 µL/g] with water treartment. D) Pluronic Functionalized 
PDMS [4 µL/g] with water treartment. 
 
Table 5-14 Flow rate of entire flow resistor with water treatment 


















1.02 E+17 2.82±0.72 3.61±0.28 
4.35 E+17 3.55±1.00 1.99±0.45 
8.80 E+17 1.04±0.22 1.72±0.04 
2.35 E+18 0.70±0.08 0.86±0.25 
 
Both static and dynamic contact angles where measured to observe the effect of the water 
treatment (Table 5-15 to 5-17). 
y = 8E+16x-0.916 






















Total resistance of entire device (m^-3) 
 Pluronic functionalized PDMS [4 µL/g]




Table 5-15 Static contact angle after water treatment 
 Plasma 
 Pluronic/PDMS [2 µL/g] Pluronic/PDMS [4 µL/g] 
Static contact angle (mean ±SD) 65.60°±2.67° 69.74°±1.65° 
 
Figure 5-14 Comparison of static contact angle with and without water treatment 
The water treated static contact angle only presented a very slight decrease in comparison 
of its non-treated counterpart (Figure 5-14). However, the dynamic contact angles presented a 
more evident change; contact angles are generally lower for the partially immersed devices since 
this treatment triggers a gradient, leading the pluronic molecules to merge to the surface of the 
microchannels (Figure 5-15). 

























Pluronic/PDMS [2 µL/g]-non treated
Pluronic/PDMS [4 µL/g]-non treated
Pluronic/PDMS [2 µL/g]-water treated
Pluronic/PDMS [4 µL/g]-water treated
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Table 5-16 Dynamic contact angle of flow resistor after water treatment (full immersion) 
 Contact angle of flow resistor after 


















1.02 E+17 97.00°±3.56° 36.92°±7.97° 
4.35 E+17 89.37°±0.92° 67.75°±4.35° 
8.80 E+17 76.83°±8.75° 56.5°±2.12° 
2.35 E+18 99.25°±0.96° 61.75°±7.80° 
 
Table 5-17 Dynamic contact of flow resistor after water treatment (patterned face in contact with 
water) 



















1.02 E+17 57.25°±4.86° 68.21°±3.87° 
4.35 E+17 54.89°±5.92° 67.00°±9.53° 
8.80 E+17 45.46°±3.60° 45.46°±3.60° 





Figure 5-15 Comparison of dynamic contact angle of water treated devices based on the 
immersion mode.  
Finally, the experimental results were validated using the equations in chapter 3. Both the 
static and dynamic contact angles were evaluated separately to determine which one would be a 
better predictor of the flow rate. Results showed that the static contact angles could provide a 
good approximate to the experimental results, while the dynamic contact angles were a little 
more complex to use in the flow equations since the contact with two of the microchannel walls 
remains unknown. 
































Pluronic/PDMS [2 µL/g]-full immersion
Pluronic/PDMS [4 µL/g]-full immersion
Pluronic/PDMS [2 µL/g]-partial immersion
Pluronic/PDMS [4 µL/g]-partial immersion
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Table 5-18 Validation data (Plasma) 
 Flow rate of the entire flow resistor mean±SD (nL/s) 
Resistance of the Flow resistor (m
-3
) 
Pluronic/PDMS [2 µL/g] 
 
Pluronic/PDMS [4 µL/g] 
1.02 E+17 9.31  8.72  
4.35 E+17 2.35  2.20  
8.80 E+17 1.17  1.09  
2.35 E+18 0.49  0.46  
Comparison of theoretical and experimental flow rate
Total resistance of flow resistor (m
-3
)





























Figure 5-16 Comparison of the experimentally measured and the theoretically calculated flow 
rate using the static contact angles. 
Table 5-18 shows the calculated flow rate using the equations in chapter 3, and assuming 
the four angles to be equivalent to the measured static contact angle. Results showed that static 
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contact angle can serve as good predictor of the flow rate, even though it does not account for the 
resistance of the microchannels (Figure 5-16). 




A major requirement for the development of point-of-care tests for the detection of 
disease analytes is the need to separate high quality plasma from whole blood efficiently and 
rapidly [151]. Methods such as centrifugation require additional equipment to separate the 
plasma fraction from the red blood cells [151], so they are not convenient for point of care 
applications. The highly asymmetric nature of a plasma separation membrane allows the cellular 
components of the blood (red cells, white cells, and platelets) to be captured in the larger pores 
without lysis, while the plasma flows down into the smaller pores on the downstream side of the 
membrane [152]. Additionally, plasma separation membranes are inexpensive and easy to 
integrate in microfluidic platforms. 
5.3.2 Method 
 
The blood separation membrane Vivid
TM
 GR (Pall Corporation) was selected for the 
utilization in the LFD because it has the highest plasma yield (~80%) according to the 
manufacturer. After the LFD was assembled, the plasma separation membrane was cut of a 
slightly smaller size than that of the window opening (18mm by 5mm), and placed on top of the 
CP1 (dull size facing up). The contact between the membrane and the CP structures needs to be 
very good for a successfully separation (Figure 4-1). The 0.9 cm
2
 membrane can separate up to 
36 µL of plasma from 45 µL of whole blood. 30 µL of whole blood were then deposited on top 
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of the membrane and slowly absorbed by it. Red blood cells, white blood cells, and platelets 
were trapped on top part of the membrane due to their size being larger than the membrane’s 
pores, and only plasma (24 µL) was able to pass through the membrane and then driven through 
the channel. 
5.4 Microscope Imaging and Data Analysis 
5.4.1 Microscope Imaging 
 
A Nikon Eclipse Ti microscope was used to image and evaluate the flow separation 
capabilities of the membrane for whole blood separation and the flow speeds for fluidic driven 
(such as plasma and PBS). During the imaging, a 40 μL droplet of liquid was placed in the inlet 
port of the device, and the fluid was transported by capillarity and a time-lapse recording was 
taken in the flow resistor area in order to observe the combined effect of the flow resistance and 
the Pluronic concentration. For the analysis of the blood separation efficiency, 30 μL of human 
whole blood (Innovative Research) were deposited on the GR plasma separation membrane, and 
a time-lapse recording was taken in the CP1 area to image a contact region of the plasma 
separation membrane with the CP1 microstructures. 
5.4.2 Data Analysis 
 
Flow speed was analyzed at the entrance and middle of the flow resistor to observe its 
dynamic change due to the pressure drop between the beginning and end of the rectangular 
microchannel [153]. The overall flow rate of the device was calculated by timing the fluid from 
entrance to exit of each component, and then dividing the volume of the specific component by 
the time the fluid spent going across it. Blood separation efficiency was analyzed using 
microscopy techniques to evaluate the quality of the plasma separated.  Flow rate and flow speed 
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analysis were performed using the time-lapse results by the NIS-Elements Viewer (Nikon 
Instruments Inc.). Dynamic contact angle measurements were performed manually using a 
protractor. For statistical analysis, data was presented as the mean ± standard deviation (SD) and 
each individual experiment was performed at least three times (n ≥3).  
5.4.3 Results  
 
High quality separated plasma (no leakage of red or white blood cells) was obtained with 
the GR membrane. Figure 5-17 shows the plasma separation process, beginning by pipetting 
human whole blood is pipetted on top of the GR membrane. 
Table 5-19 compares the average velocity of the fluid at the entrance of the flow resistor 
for commercially available plasma (separated using other methods such as centrifugation) and 
plasma separated using the Vivid GR separation membrane. The velocity of the separated plasma 
was highly consistent with that of the centrifuged plasma.  
 
Figure 5-17 Plasma separation from whole blood. A) Ready to separate. B) Start to separate. C) 






Table 5-19 Comparison of flow rates of the flow resistor (entrance) for separated plasma from 
whole blood and just plasma. The substrate used was Pluronic functionalized PDMS 
(Pluronic/PDMS [4 µL/g]). 










Average Velocity  
mean ± SD (µm/s) 
375±73.54 Average Velocity  
mean ± SD (µm/s) 
385±24.09 
Depth of channel 
(µm) 
25 Depth of channel 
(µm) 
25 
Width of channel 
(µm) 
200 Width of channel 
(µm) 
200 




Chapter 6 Conclusions and Future Work 
In order to bridge the healthcare gap between developing and developed countries, there 
is a growing need for integrated, low cost solutions that are easy to handle, and that are able to 
provide high quality results. Microfuidics is a powerful alternative for addressing this objective, 
however, most of current technologies are not fully integrated in-chip, and therefore require 
external equipment which is expensive and not portable.  
The LFD developed in this work is able to overcome this problematic, by integrating all 
functions in-chip, allowing for the performance of entire laboratory protocols for immunoassays 
without the need of any external equipment. The LFD combines the ability to separate plasma 
from a small sample of whole blood, initiate and control the fluid flow taking advantage of 
capillary forces, and the potential to implement to implement a wide range of immunoassays. 
The patient would need only to provide a sample droplet of whole blood, and would be able to 
see the results within the course of several minutes. This platform is sensitive, versatile, and easy 
to use, which makes it a great alternative for point-of-care testing.  
In this work PDMS was functionalized using Pluronic F127, in order to render it 
hydrophilic. Because time is a critical factor in performing sandwich immunoassays, flow rate 
was controlled by several factors, including the structures size and position in thee capillary 
pumps, the concentration of pluronic, and by tuning the resistance of the flow resistor. It was 
observed from the experiments that the resistance of the flow resistor had the greatest effect on 
the flow rate of the fluids. Plasma flow rates ranging between 0.43 and 18.60 nL/s were achieved 
in the flow resistor, and between 0.99 and 61.30 nL/s in the whole device. Even though water 
treatment presents an alternative for stabilizing the pluronic and preventing non-specific 
absorption, it is key to find ways to control evaporation. 
Efforts are currently been made to test the device using different detection techniques 
such as colorimetric and fluorescence, for the detection of Immunoglobulin G (IgG), and 
traumatic brain injury biomarkers, but the LFD can be used for a diversity of targets. 
The current platform is designed for the detection of a single biomarker, but it will be 
further modified to obtain multiplexing capabilities, which would allow generating more 
meaningful and conclusive information for clinical diagnosis (Figure 6-1).  
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